Qiagen's BioRobot platforms straddle the boundary separating smaller stand-alone systems from more open-ended workstations, but still rely heavily on the use of standardized solutions for each ...

VENLO, The Netherlands, July 22, 2025--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of its new QIAseq xHYB Long Read Panels, a suite of target enrichment solutions ...

VENLO, Netherlands, July 08, 2025 -- (BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) today announced plans to release results for the second quarter of 2025.

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions, enabling customers to extract and gain valuable molecular insights from samples ...

Qiagen (NYSE: QGEN) NV stock, with a market capitalization of $10.5 billion, has reached a new 52-week high, trading at 48.91 USD. According to InvestingPro analysis, the stock is currently ...

VENLO, Netherlands - QIAGEN (NYSE:QGEN) announced Tuesday the introduction of its QIAseq xHYB Long Read Panels, a new suite of target enrichment solutions designed for analyzing complex genomic ...

QIAGEN’s expanded portfolio now allows researchers to choose between short- and long-read sequencing – or combine them – depending on their sample type and research objectives. QIAGEN’s end-to-end NGS ...